Neuropace
NPCE
NPCE
41 hedge funds and large institutions have $156M invested in Neuropace in 2023 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
12.24% less ownership
Funds ownership: 69.89% → 57.65% (-12%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
41
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$26M | |
| 2 | +$995K | |
| 3 | +$660K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$436K |
| 5 |
Jane Street
New York
|
+$380K |
Top Sellers
| 1 | -$2.46M | |
| 2 | -$778K | |
| 3 | -$477K | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$341K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$270K |